Based on research at University of Notre Dame, Happe Spine is working on implants for interbody spinal fusion.
Happe Spine, a US-based implant technology producer based on research at University of Notre Dame, has raised an undisclosed sum from medical device-focused venture capital funds Cultivate(MD) Fund I and Cultivate(MD) Fund II.
Founded in July 2018, Happe Spine is commercialising a material to construct partial and fully porous, bioactive Peek implants that can be used for interbody spinal fusion.
The technology is based on research by Ryan Roeder in Notre Dame’s Department of Aerospace and Mechanical Engineering.
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
